Coronary Artery Disease · 2015 · 57 citations · 16 references
MedicineCardiologyInternal MedicineClinical CardiologyDiabetologyGlycobiologyCardiovascular DiseaseCardiovascular PathologyCardiovascular PathophysiologyCoronary Artery DiseaseDiabetes MellitusMetabolic SyndromeAtherosclerosis Molecular MechanismsAtherosclerosis RiskAtherosclerotic Plaque CharacterizationComputed Tomography AngiographyComputed Tomography Coronary AngiographyDiabetes-associated Cardiac RiskLectinsPlaque Burden Quantification
BACKGROUND: Levels of galectin-3, a member of a family of soluble β-galactoside-binding lectins, are reported to be higher in patients with type 2 diabetes mellitus (DM) and metabolic syndrome. Conflicting results exist on the effects of galectin-3 in diabetic patients. The aim of this study was to investigate the relationship between galectin-3 levels and coronary artery disease (CAD), coronary plaque burden, and plaque structures in patients with type 2 DM. PATIENTS AND METHODS: A total of 158 consecutive patients with type 2 DM undergoing planned coronary computed tomography angiography (CCTA) were included in this study. The study population was divided into CAD and non-CAD groups according to the presence of CCTA-determined coronary atherosclerosis. RESULTS: Galectin-3 concentrations were significantly higher in the CAD group than in the non-CAD group (1412.0 ± 441.7 vs. 830.2 ± 434.9 pg/ml, P < 0.001). Galectin-3 levels were correlated positively with BMI, high-sensitivity C-reactive protein, the total number of diseased vessels, the number of plaques (all, P < 0.001), and the calcified plaque type (P = 0.001). In addition, galectin-3 levels were found to be a significant independent predictor of coronary atherosclerosis in type 2 diabetic patients (P = 021; odds ratio, 1.002; 95% confidence interval, 1.000-1.003). CONCLUSION: Galectin-3 is a novel, promising biomarker that may help identify type 2 diabetic patients who may require early CAD intervention because of the potential risk of coronary atherosclerosis.
16
2013 ESH/ESC Guidelines for the management of arterial hypertension
Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz et al. · Journal of Hypertension · 2013 · 5.7K citations
Željko Reiner, Alberico L. Catapano, Guy De Backer et al. · European Heart Journal · 2011 · 3.5K citations · Full text
Austen Wg, Je. Edwards, RL Frye et al. · Circulation · 1975 · 3.3K citations · Full text
Medicine, Cardiology, Surgery +17